Created in 2015 (United States), INREBIC own
126 sister brands
and 17477 competing brands.
INREBIC is a brand of Celgene, listed on the stock exchange of New York.
INREBIC belongs to the Drug Manufacturers business sector.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.